Summary

Population-based cancer survival analysis evaluates the proportion of individuals diagnosed with cancer who remain alive for defined periods—commonly one, three and five years—after diagnosis. Unlike clinical trials, which enrol selected patient groups, population-based studies draw upon comprehensive cancer registries that capture all incident cases within specified geographical regions. This approach yields unbiased, real-world estimates that reflect the combined effects of early detection, diagnostic pathways, therapeutic interventions and health-system performance. Key metrics include net survival, which adjusts for background mortality from other causes, and relative survival, which compares observed survival with expected survival in the general population. Age standardisation ensures valid comparisons over time and across regions by controlling for demographic differences. Analytical frameworks such as the cohort and complete approaches enable robust temporal trend analysis, while statistical estimators like the Pohar Perme method deliver unbiased survival calculations. Insights from these analyses inform national cancer control strategies, highlight inequities in access and outcomes, and underpin evaluation of screening programmes and treatment optimisation. International surveillance initiatives employ harmonised protocols to facilitate global benchmarking and to assess the impact of policy interventions on survival disparities.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Population-Based Cancer Survival Analysis publication trend

The graph below shows the total number of articles in population-based cancer survival analysis across all publications each year (not limited to Nature Index journals).

Technical terms

Net survival: The proportion of cancer patients who survive after removing mortality from other causes.
Relative survival: The ratio of observed patient survival to expected survival in a comparable general population.
Age standardisation: Adjustment of survival estimates to a uniform age distribution to enable fair comparisons.
Life table: A demographic model summarising mortality rates by age and sex, used to estimate background mortality.
Cohort and complete approaches: Statistical designs for survival estimation; the cohort approach analyses fixed diagnosis periods, while the complete approach incorporates all available follow-up.
Pohar Perme estimator: An unbiased statistical method for calculating net survival that accounts for varying background mortality.

References

  1. Population‐based cancer survival in the United States: Data, quality control, and statistical methods. Cancer (2017).
  2. Public health surveillance of cancer survival in the United States and worldwide: The contribution of the CONCORD programme. Cancer (2017).
  3. Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods. BMC Cancer (2017).
  4. The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival. Cancer Epidemiology (2020).
  5. Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990–2016: The NORDCAN survival studies. European Journal of Cancer (2022).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.